You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
7 August 2026 - Swedish biotech company BioInvent International AB (STO:BINV) announced on Friday that the US Food and Drug Administration (FDA) has granted Fast Track designation to its first-in-class anti-TNFR2 antibody BI-1808, in combination with...
7 August 2026 - Northwest Biotherapeutics (NWBio) (OTCQB:NWBO), a biotechnology company developing DCVax personalised immune therapies for solid tumour cancers, announced on Thursday that it has entered into a non-binding Memorandum of Understanding ...
7 August 2026 - Medical device manufacturer Amsino International Inc announced on Thursday that it has been awarded a contract by healthcare company Vizient for enteral syringes, effective 1 August 2026.Amsino manufactures enteral syringes in both No...
7 August 2026 - Clinical-stage biopharmaceutical company Energenesis Biomedical Co Ltd (TWSE:6657) announced on Thursday that it has entered into a joint development agreement with Taiwan Tanabe Seiyaku Co Ltd, a subsidiary of Tanabe Pharma Corporati...
6 August 2026 - Swiss biotechnology company Roche (SIX: RO, ROG; OTCQX: RHHBY), in collaboration with subsidiary TIB MOLBIOL, announced on Thursday the launch of two new real-time PCR tests to help laboratories detect the Cyclospora cayetanensis para...
Olio Labs reveals study demonstrating AI-driven in vivo platform can predict clinical trial outcomes
6 August 2026 - Biotechnology company Olio Labs on Wednesday published research showing that its preclinical in vivo platform predicts human clinical trial outcomes ranging from gastrointestinal adverse events to cardiac toxicity.Rodent studies have ...
6 August 2026 - China-based biopharmaceutical company Innovent Biologics Inc (HKEX: 01801) announced on Wednesday that the first patient has been dosed in a pivotal study evaluating IBI363 (Takeda R&D code: TAK-928), a potential first-in-class PD...